e-Incubator Technology Provides Real-Time Imaging of Bioengineered Tissues in a Controlled Unit
By LabMedica International staff writers Posted on 24 Nov 2014 |
A new e-incubator, an innovative miniature incubator that is compatible with magnetic resonance imaging (MRI), enables scientists to grow tissue-engineered constructs under a controlled setting and to study their growth and development in real time without risk of contamination or damage.
Offering the potential to test engineered tissues before human transplantation increases the success rate of implantation, and accelerates the translation of tissue engineering methods from the lab to the clinic, the novel e-incubator was described in the journal Tissue Engineering, Part C.
Shadi Othman, PhD, Karin Wartella, PhD, Vahid Khalilzad Sharghi, and Huihui Xu, PhD, from the University of Nebraska-Lincoln (USA), presented their findings of a validation study using the device to culture tissue-engineered bone constructs for four weeks. The e-incubator is a standalone unit that automatically detects and regulates internal conditions such as temperature, carbon dioxide levels, and pH via a microcontroller. It performs media exchange to feed the cultures and remove waste products. The current design is compatible with MRI to monitor the constructs without removing them from the incubator. With proper adjustments, compatibility with other imaging technologies including computed tomography [CT] and optical imaging is also possible.”
“Calibratable, hands-free tissue development environments are becoming increasingly important for the engineering of implantable tissues,” said Tissue Engineering co-editor-in-chief Peter C. Johnson, MD, vice president, research and development, Avery Dennison Medical Solutions (Chicago, IL, USA), and president and CEO, Scintellix, LLC (Raleigh, NC, USA). “In this new development, noninvasive imaging modalities are added to the spectrum of sensing and environmental capabilities that heretofore have included temperature, humidity, light, physical force, and electromagnetism. This represents a solid advance for the field.”
Related Links:
University of Nebraska-Lincoln
Offering the potential to test engineered tissues before human transplantation increases the success rate of implantation, and accelerates the translation of tissue engineering methods from the lab to the clinic, the novel e-incubator was described in the journal Tissue Engineering, Part C.
Shadi Othman, PhD, Karin Wartella, PhD, Vahid Khalilzad Sharghi, and Huihui Xu, PhD, from the University of Nebraska-Lincoln (USA), presented their findings of a validation study using the device to culture tissue-engineered bone constructs for four weeks. The e-incubator is a standalone unit that automatically detects and regulates internal conditions such as temperature, carbon dioxide levels, and pH via a microcontroller. It performs media exchange to feed the cultures and remove waste products. The current design is compatible with MRI to monitor the constructs without removing them from the incubator. With proper adjustments, compatibility with other imaging technologies including computed tomography [CT] and optical imaging is also possible.”
“Calibratable, hands-free tissue development environments are becoming increasingly important for the engineering of implantable tissues,” said Tissue Engineering co-editor-in-chief Peter C. Johnson, MD, vice president, research and development, Avery Dennison Medical Solutions (Chicago, IL, USA), and president and CEO, Scintellix, LLC (Raleigh, NC, USA). “In this new development, noninvasive imaging modalities are added to the spectrum of sensing and environmental capabilities that heretofore have included temperature, humidity, light, physical force, and electromagnetism. This represents a solid advance for the field.”
Related Links:
University of Nebraska-Lincoln
Latest BioResearch News
- Genome Analysis Predicts Likelihood of Neurodisability in Oxygen-Deprived Newborns
- Gene Panel Predicts Disease Progession for Patients with B-cell Lymphoma
- New Method Simplifies Preparation of Tumor Genomic DNA Libraries
- New Tool Developed for Diagnosis of Chronic HBV Infection
- Panel of Genetic Loci Accurately Predicts Risk of Developing Gout
- Disrupted TGFB Signaling Linked to Increased Cancer-Related Bacteria
- Gene Fusion Protein Proposed as Prostate Cancer Biomarker
- NIV Test to Diagnose and Monitor Vascular Complications in Diabetes
- Semen Exosome MicroRNA Proves Biomarker for Prostate Cancer
- Genetic Loci Link Plasma Lipid Levels to CVD Risk
- Newly Identified Gene Network Aids in Early Diagnosis of Autism Spectrum Disorder
- Link Confirmed between Living in Poverty and Developing Diseases
- Genomic Study Identifies Kidney Disease Loci in Type I Diabetes Patients
- Liquid Biopsy More Effective for Analyzing Tumor Drug Resistance Mutations
- New Liquid Biopsy Assay Reveals Host-Pathogen Interactions
- Method Developed for Enriching Trophoblast Population in Samples